NCT05314595

Brief Summary

Aim of the study Primary outcomes:

  1. 1.The effect of bilateral uterine artery ligation in reducing intraoperative bleeding in women underwent PPC as a conservative surgical technique.
  2. 2.Decrease surgical time.
  3. 3.Associated maternal morbidity and mortality.
  4. 4.Amount of blood transfusion
  5. 5.Difference in hematocrit value before and after delivery

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2022

Completed
21 days until next milestone

Study Start

First participant enrolled

April 1, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 6, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

April 6, 2022

Status Verified

April 1, 2022

Enrollment Period

4 months

First QC Date

March 11, 2022

Last Update Submit

April 5, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • bilateral uterine artery ligation

    1\. The effect of bilateral uterine artery ligation and estimation of blood volume loss (VMBL): direct measurement of blood loss in volume units (mL);

    30 months

Study Arms (1)

modified technique

EXPERIMENTAL

women were underwent modified technique (PPC+ bilateral uterine artery ligation)

Procedure: bilateral uterine artery ligation

Interventions

* Spinal anaethesia with intrathecal morphia * Transverse skin incision * Adequate dissection of the bladder. * Incision of the uterus above placental edge. * Delivery of the fetus. * Delayed cord clamping (60 seconds) if the baby appears well. * Exteriorization of the uterus. * Start Oxytocin infusion and uterine massage to ensure good uterine contractions immediately after delivery of the fetus. No trials of placental delivery will be made at this point. * At this point, a gentile trial to deliver the placenta is performed * A catheter is placed in the cervix from above to secure the cervical opening * Compression is applied to the site of bleeding from placenta site * Placental pouch is marked by multiple allies and is closed down to the multiple-8 suture. * Blood loss is measured using the suction device and coated socked towels. In modified PPC, Bilateral uterine artery ligation will be done after exteriorization of the uterus in order to minimize the blood loss.

modified technique

Eligibility Criteria

Age16 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Previous operations
  • Gestational age (28 weeks)
  • Prenatally suspected PAS based on sonographic and/or MRI findings and/or intrapartum diagnosis of PAS.
  • Authorization to participate in the study

You may not qualify if:

  • Coagulopathies
  • Chronic renal or hepatic impairment (baseline first trimester labs are beyond normal range for pregnancy)
  • Delivery in an outside hospital (patients referred for ongoing massive bleeding due to PAS)
  • Patients coming in emergency condition with bleeding or in labour.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut Medical School

Asyut, 71511, Egypt

Location

Related Publications (4)

  • Cal M, Ayres-de-Campos D, Jauniaux E. International survey of practices used in the diagnosis and management of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018 Mar;140(3):307-311. doi: 10.1002/ijgo.12391. Epub 2017 Dec 22.

    PMID: 29149470BACKGROUND
  • Tan CH, Tay KH, Sheah K, Kwek K, Wong K, Tan HK, Tan BS. Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR Am J Roentgenol. 2007 Nov;189(5):1158-63. doi: 10.2214/AJR.07.2417.

    PMID: 17954654BACKGROUND
  • Ye M, Yin Z, Xue M, Deng X. High-intensity focused ultrasound combined with hysteroscopic resection for the treatment of placenta accreta. BJOG. 2017 Aug;124(Suppl 3):71-77. doi: 10.1111/1471-0528.14743.

    PMID: 28856861BACKGROUND
  • Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA, Moawad AH, Caritis SN, Harper M, Wapner RJ, Sorokin Y, Miodovnik M, Carpenter M, Peaceman AM, O'Sullivan MJ, Sibai B, Langer O, Thorp JM, Ramin SM, Mercer BM; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol. 2006 Jun;107(6):1226-32. doi: 10.1097/01.AOG.0000219750.79480.84.

    PMID: 16738145BACKGROUND

Related Links

MeSH Terms

Conditions

Placenta Accreta

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPlacenta Diseases

Study Officials

  • Kamal M Zahran, Professor

    Assiut medical school

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 11, 2022

First Posted

April 6, 2022

Study Start

April 1, 2022

Primary Completion

August 1, 2022

Study Completion

September 1, 2022

Last Updated

April 6, 2022

Record last verified: 2022-04

Locations